Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000214797 | SCV000279758 | uncertain significance | not provided | 2017-01-12 | criteria provided, single submitter | clinical testing | The c.1058-6 C>G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.1058-6 C>G variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Several in-silico splice prediction models predict that c.1058-6 C>G damages the natural splice acceptor site for intron 9, and may lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000705036 | SCV000834015 | likely benign | TNF receptor-associated periodic fever syndrome (TRAPS) | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262829 | SCV002543077 | uncertain significance | Autoinflammatory syndrome | 2020-06-04 | criteria provided, single submitter | clinical testing |